FR2767M - Nouveau médicament antimalarique a effet retard. - Google Patents

Nouveau médicament antimalarique a effet retard.

Info

Publication number
FR2767M
FR2767M FR939762A FR939762A FR2767M FR 2767 M FR2767 M FR 2767M FR 939762 A FR939762 A FR 939762A FR 939762 A FR939762 A FR 939762A FR 2767 M FR2767 M FR 2767M
Authority
FR
France
Prior art keywords
depot effect
antimalarial drug
new antimalarial
new
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR939762A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Application granted granted Critical
Publication of FR2767M publication Critical patent/FR2767M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FR939762A 1962-06-29 1963-06-28 Nouveau médicament antimalarique a effet retard. Active FR2767M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US206172A US3215600A (en) 1962-06-29 1962-06-29 Antimalarial composition containing an acylated sulfonylaniline with triazine or pyrimidine salt, and method of use

Publications (1)

Publication Number Publication Date
FR2767M true FR2767M (fr) 1964-08-31

Family

ID=22765272

Family Applications (1)

Application Number Title Priority Date Filing Date
FR939762A Active FR2767M (fr) 1962-06-29 1963-06-28 Nouveau médicament antimalarique a effet retard.

Country Status (9)

Country Link
US (1) US3215600A (de)
AT (1) AT263205B (de)
BE (1) BE634276A (de)
BR (1) BR6350289D0 (de)
ES (1) ES289479A1 (de)
FR (1) FR2767M (de)
GB (1) GB999121A (de)
NL (1) NL6614309A (de)
SE (1) SE320460B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876785A (en) * 1967-12-06 1975-04-08 Beecham Group Ltd 4,6-diamino-1,2-dihydro-arylmethoxy-1,3,5-triazines for combating plasmodium parasites
US3761590A (en) * 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns
CA964192A (en) * 1970-07-21 1975-03-11 Roy H. Reiner Long-acting narcotic antagonist formulations containing pamoate salts of dihydronormorphinone
WO1991008667A1 (en) * 1989-12-07 1991-06-27 Protos Corporation Inhibitors of pneumocystis carinii dihydrofolate reductase
GB0001565D0 (en) * 2000-01-24 2000-03-15 Isis Innovation Dihydrofolate reductase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2900385A (en) * 1959-08-18 Dihydrotriazines and method of
US1872826A (en) * 1927-08-16 1932-08-23 Winthrop Chem Co Inc Soluble salts of organic bases and the process of preparing the same
GB813560A (en) * 1957-02-28 1959-05-21 Sterling Drug Inc Substituted-1:2-dihydro-1:3:5-triazines

Also Published As

Publication number Publication date
BE634276A (fr) 1963-11-04
BR6350289D0 (pt) 1973-08-02
NL6614309A (de) 1966-12-27
SE320460B (de) 1970-02-09
ES289479A1 (es) 1963-11-01
US3215600A (en) 1965-11-02
AT263205B (de) 1968-07-10
GB999121A (en) 1965-07-21

Similar Documents

Publication Publication Date Title
FR2767M (fr) Nouveau médicament antimalarique a effet retard.
FR2867M (fr) Nouvelles compositions thérapeutiques a effet carcinolytique.
FR3361M (fr) Nouveau médicament anthelmintique.
FR8477M (fr) Nouveau médicament hypocalcémique.
BE638361A (fr) Nouveau médicament lipotrope.
FR2400M (fr) Nouveau médicament antalgique neuro-trophique et anti-anémique.
FR2178M (fr) Nouveau médicament.
FR2522M (fr) Nouveau médicament anbolisant.
BE763101A (fr) Nouveau medicament a action vasodilatatrice et spasmotique.
FR1864M (fr) Médicament nouveau a base de mercapto-acyl-amido-5-nitrothiazoles.
FR2519M (fr) Médicament analgésique.
FR2511M (fr) Nouveau médicament a propriétés antiinfectieuses.
FR2357M (fr) Nouveau médicament a action anti-histaminique et anti-tussive.
FR1486M (fr) Nouveau médicament anti-coagulant.
FR2945M (fr) Nouveau médicament a propriétés antimycotiques.
FR2082M (fr) Nouveau médicament sédatif.
BE639681A (fr) Nouveau médicament diurétique.
FR2567M (fr) Nouveau médicament antiathéromateux et antilipémique.
FR1839M (fr) Nouveau médicament antispasmodique.
FR212M (fr) Nouveau laxatif a effet prolongé.
FR3643M (fr) Nouveau médicament détoxifiant.
FR3039M (fr) Nouveau médicament antalgique, neuro-trophique et anti-pyrétique.
FR1361M (fr) Nouveau médicament hypocholestérolémique.
FR3307M (fr) Nouveau médicament fongistatique.
FR1072M (fr) Nouveau médicament a action hypocholestérolémiante.